 | Up a level |
Journal Article
Herbrand, Amanda Katherina, Schmitt, Andreas M., Briel, Matthias 
ORCID: 0000-0002-2070-5230, Ewald, Hannah ORCID: 0000-0002-5081-1093, Goldkuhle, Marius, Diem, Stefan, Hoogkamer, Anouk, Joerger, Markus, Moffa, Giusi ORCID: 0000-0002-2739-0454, Novak, Urban, Hemkens, Lars G. and Kasenda, Benjamin ORCID: 0000-0003-0110-8585
(2021).
Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs.
JAMA Netw. Open, 4 (3).
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 2574-3805
Joerger, Markus, Cassier, Philippe, Penel, Nicolas, Cathomas, Richard, Richly, Heike, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Nogova, Lucia, Tai, David Wai-Meng, Sayehli, Cyrus, Gruellich, Carsten, Grande, Enrique, Navarro, Alejandra, Park, Se Hoon, Gillessen, Silke, Nogai, Hendrik, Bender, Sebastian, Ellinghaus, Peter and Schuler, Martin H. (2018). Rogaratinib treatment of patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression. J. Clin. Oncol., 36 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Joerger, Markus, Cassier, Philippe Alexandre, Penel, Nicolas, Cathomas, Richard, Richly, Heike, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Nogova, Lucia, Tai, David Wai-Meng, Sayehli, Cyrus, Grullich, Carsten, Grande, Enrique, Navarro, Alejandro, Park, Se Hoon, Nogai, Hendrik, Bender, Sebastian, Ellinghaus, Peter and Schuler, Martin H. (2018). Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Kempf, Emmanuelle, Penel, Nicolas, Tournigand, Christophe, Gajate, Pablo, Tan, Daniel Shao-Weng, Cassier, Philippe, Nogova, Lucia, Cathomas, Richard, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Sayehli, Cyrus, Navarro, Alejandro, Park, Se Hoon, Piciu, Ana-Maria, Bender, Sebastian, Nogai, Hendrik, Ellinghaus, Peter, Joerger, Markus and Schuler, Martin H. (2020). Phase I experience with rogaratinib in patients (pts) with urothelial carcinoma (UC) selected based on FGFR mRNA overexpression. J. Clin. Oncol., 38 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Mc Laughlin, Anna M. ORCID: 0000-0002-5936-1877, Schmulenson, Eduard ORCID: 0000-0002-8026-609X, Teplytska, Olga, Zimmermann, Sebastian ORCID: 0000-0002-6282-297X, Opitz, Patrick, Groenland, Stefanie L., Huitema, Alwin D. R., Steeghs, Neeltje, Mueller, Lothar, Fuxius, Stefan, Illerhaus, Gerald, Joerger, Markus ORCID: 0000-0001-6602-6287, Mayer, Frank, Fuhr, Uwe, Holdenrieder, Stefan, Hempel, Georg ORCID: 0000-0002-5790-6423, Scherf-Clavel, Oliver ORCID: 0000-0002-1967-9231, Jaehde, Ulrich and Kloft, Charlotte
(2021).
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol.
Cancers, 13 (24).
BASEL:
MDPI.
ISSN 2072-6694
Schuler, Martin, Cho, Byoung Chuf, Sayehli, Cyrus Michael, Navarro, Alejandro, Soo, Ross A., Richly, Heike, Cassier, Philippe Alexandre, Tai, David, Penel, Nicolas, Nagoya, Lucia, Park, Se Hoon, Schostak, Martin, Gajate, Pablo, Cathomas, Richard, Rajagopalan, Prabhu, Grevel, Joachim ORCID: 0000-0002-4635-7211, Bender, Sebastian, Boix, Oliver, Nogai, Hendrik, Ocker, Matthias ORCID: 0000-0001-8263-6288, Eflinghaus, Peter and Joerger, Markus
(2019).
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study.
Lancet Oncol., 20 (10).
S. 1454 - 1467.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488